Chargement en cours...

Immunotherapy: Who is Eligible?

Recurrent and/or metastatic head and neck cancer portends a poor prognosis with traditional treatments, but current immunotherapy with immune checkpoint inhibitors has the potential to improve these clinical outcomes. This review focuses on the major breakthroughs that have led to our current unders...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Otolaryngol Clin North Am
Auteurs principaux: Wang, Daniel, Gilbert, Jill, Kim, Young J.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282181/
https://ncbi.nlm.nih.gov/pubmed/28755708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.otc.2017.04.006
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!